1. Home
  2. NATR vs LYEL Comparison

NATR vs LYEL Comparison

Compare NATR & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nature's Sunshine Products Inc.

NATR

Nature's Sunshine Products Inc.

HOLD

Current Price

$27.24

Market Cap

424.6M

Sector

Health Care

ML Signal

HOLD

Logo Lyell Immunopharma Inc.

LYEL

Lyell Immunopharma Inc.

HOLD

Current Price

$24.23

Market Cap

556.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NATR
LYEL
Founded
1972
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
424.6M
556.1M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
NATR
LYEL
Price
$27.24
$24.23
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$28.33
$30.60
AVG Volume (30 Days)
91.4K
75.2K
Earning Date
05-05-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
165.00
N/A
EPS
1.06
N/A
Revenue
$480,144,000.00
$36,000.00
Revenue This Year
$7.76
N/A
Revenue Next Year
$4.82
$8,712.13
P/E Ratio
$25.79
N/A
Revenue Growth
5.67
N/A
52 Week Low
$11.27
$0.39
52 Week High
$28.14
$45.00

Technical Indicators

Market Signals
Indicator
NATR
LYEL
Relative Strength Index (RSI) 64.31 59.93
Support Level $13.70 $21.27
Resistance Level $28.00 $27.30
Average True Range (ATR) 0.78 1.65
MACD 0.26 0.41
Stochastic Oscillator 92.69 90.43

Price Performance

Historical Comparison
NATR
LYEL

About NATR Nature's Sunshine Products Inc.

Natures Sunshine Products Inc is a natural health and wellness company mainly engaged in the manufacturing and direct selling of nutritional and personal care products. The following Companies' product lines include: General health: Assorted health products related to blood sugar, bone health, cellular health, etc. Immune: offer products that support and strengthen the human immune system, Cardiovascular: Ingredients to give the cardiovascular system optimum support. Digestive: regulates intestinal and digestive functions, Personal care: personal care products for external use, and Weight management: to simplify the weight management process by providing healthy meal replacements. Business segment: Asia, Europe, North America, Latin America, and Other. The majority of revenue is from Asia.

About LYEL Lyell Immunopharma Inc.

Lyell Immunopharma Inc s a late-stage clinical cell therapy company advancing a pipeline of proprietary next-generation autologous chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors. The Company's product candidate, rondecabtagene autoleucel (ronde-cel, also known as LYL314), is an autologous dual-targeting CD19/CD20 CAR T-cell therapy in development for large B-cell lymphoma (LBCL). The Company has recently acquired exclusive rights outside of mainland China, Hong Kong, Macau and Taiwan, to a novel guanylyl cyclase C (GCC)-targeted CAR T-cell product candidate in early clinical development for refractory metastatic colorectal cancer (mCRC) and other GCC-expressing cancers.

Share on Social Networks: